Reuters logo
BRIEF-TG Therapeutics qtrly net loss per common share $0.48
November 8, 2017 / 12:53 PM / 10 days ago

BRIEF-TG Therapeutics qtrly net loss per common share $0.48

Nov 8 (Reuters) - TG Therapeutics Inc:

* TG therapeutics, inc. Provides business update and reports third quarter 2017 financial results

* TG therapeutics inc - qtrly net loss per common share $0.48

* Q3 earnings per share view $-0.43 -- Thomson Reuters I/B/E/S

* TG therapeutics inc - believes cash and cash equivalents will be sufficient to fund planned operations through 2018​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below